Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer

Head and neck squamous cell carcinomas (HNSCC) form a large heterogeneous group of tumors and have a relatively poor outcome in advanced cases. Revealing the underlying genetic mutations in HNSCC facilitates the development of diagnostic biomarkers, which might lead to improved diagnosis and post tr...

Descripción completa

Detalles Bibliográficos
Autores principales: van Ginkel, Joost H., de Leng, Wendy W.J., de Bree, Remco, van Es, Robert J.J., Willems, Stefan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308673/
https://www.ncbi.nlm.nih.gov/pubmed/27528217
http://dx.doi.org/10.18632/oncotarget.11196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308673/
https://www.ncbi.nlm.nih.gov/pubmed/27528217
http://dx.doi.org/10.18632/oncotarget.11196

Ejemplares similares